AUG 08, 2016 11:52 AM PDT

Immune-Mediated Neuropathies Caused By Autoantibodies

WRITTEN BY: Kara Marker
Whether chronic or acute, patients with inflammatory nerve disorders are often out of luck for a quick diagnosis or accurate treatment. A new study could soon contribute to improving the circumstances of these patients though: from the University of Wurzburg, researchers are looking at a specific protein as the culprit for some cases of immune-mediated neuropathy.
Credit: faculty.ivytech.edu
Inflammatory nerve disorders develop quickly, often resulting in severe paralysis. There are currently zero diagnostic tests in existence that can accurately diagnose an immune-mediated neuropathies. Patients are then often treated with corticosteroids or antibodies that that have little to no therapeutic effect. Based on results from their current study, published in the journal Brain, and previous studies with similar findings,  Wurzburg scientists recommend a new approach.

In a study of 35 patients with a chronic inflammatory nerve disorder, called chronic inflammatory demyelinating polyneuropathy (CIDP), and 22 patients an acute disorder called Guillain-Barre syndrome, researchers looked for any evidence of autoantibodies targeting a specific component of the nerve fiber called Caspr. This protein helps to build the “Nodes of Ranvier,” a nerve fiber structure that serves as a gap between sections of myelin sheath that forward nerve impulses. 

The myelin sheath acts as an “electrical insulator” that propagates nerve impulses to the attached Nodes of Ranvier, and when antibodies attack Caspr, the structure of the nodes is destroyed and nerve function is rendered drastically impaired.
Credit: www.keyword-suggestions.com
Wurzburg researchers found autoantibodies targeting Caspr in the blood of one patient with CIDP and one patient with Guillain-Barre syndrome. With confirmation of the causation behind these patients’ disease, the researchers successful administered rituximab to inhibit antibody function and reduce the symptoms of their neuropathy. Rituximab is a CD20-directed cytolytic antibody used for treating patients with conditions like non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, and rheumatoid arthritis.

Antibodies targeting Caspr proteins may not be the full answer to immune-mediated neuropathies, but researchers from the study believe that antibodies targeting other nerve fiber-related proteins could fill in the gaps of causation. In fact, Caspr is just the third protein in this area of the Nodes of Ranvier for which autoantibodies have been identified. The other two proteins involved with immune-mediated neuropathies include Contactin-1 and Neurofascin-155. Scientists are starting to see that depending on which nerve fiber protein is being targeted by autoantibodies, a patient will exhibit different features.
 
In the future, researchers plan to conduct blood tests for known autoantibodies that target nerve fiber-related proteins, as well as continue to search for other proteins being targeted that cause neuropathies.
 


Sources: Therapeutic Advances in Neurological Disorders, University of Wurzburg, Basic Neurochemistry: Molecular, Cellular and Medical Aspects. 6th edition, Gene.com
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JAN 06, 2021
Immunology
Probiotic Boosters Are Lifesavers for Preterm Babies
JAN 06, 2021
Probiotic Boosters Are Lifesavers for Preterm Babies
When administered shortly after birth, a recent study has found that the supplementation combo of probiotics and prebiot ...
MAR 31, 2021
Microbiology
Deep-Sea Microbes Are 'Invisible' to the Human Immune System
MAR 31, 2021
Deep-Sea Microbes Are 'Invisible' to the Human Immune System
Scientists took an exploratory journey to a place in the central Pacific Ocean in Kirbati called the Phoenix Islands Pro ...
APR 22, 2021
Drug Discovery & Development
mRNA Covid Vaccines May Protect Against New Strains and Common Cold
APR 22, 2021
mRNA Covid Vaccines May Protect Against New Strains and Common Cold
Researchers from Johns Hopkins have found that the mRNA Covid vaccines developed by Pfizer and Moderna not only work wit ...
APR 27, 2021
Immunology
Breakthrough Malaria Vaccine Is a Ray of Hope
APR 27, 2021
Breakthrough Malaria Vaccine Is a Ray of Hope
University of Oxford scientists have developed a vaccine against malaria, which they describe as having “unprecede ...
APR 27, 2021
Neuroscience
Leaky Blood-Brain Barrier Linked to Schizophrenia
APR 27, 2021
Leaky Blood-Brain Barrier Linked to Schizophrenia
Researchers from the University of Pennsylvania have found that people with schizophrenia may have a more permeable bloo ...
MAY 13, 2021
Immunology
Tumors Hide From the Immune System by Masquerading as Baby Cells
MAY 13, 2021
Tumors Hide From the Immune System by Masquerading as Baby Cells
The immune system is programmed to recognize foreign bodies as potentially dangerous, promptly removing them before the ...
Loading Comments...